Your browser doesn't support javascript.
loading
The ddn Trp20Stop Mutation and Its Association with Lineage 4.5 and Resistance to Delamanid and Pretomanid in Mycobacterium tuberculosis.
Mansjö, Mikael; Karlsson Lindsjö, Oskar; Grönfors Seeth, Christina; Groenheit, Ramona; Werngren, Jim.
Afiliación
  • Mansjö M; Public Health Agency of Swedengrid.419734.c, Solna, Sweden.
  • Karlsson Lindsjö O; Public Health Agency of Swedengrid.419734.c, Solna, Sweden.
  • Grönfors Seeth C; Public Health Agency of Swedengrid.419734.c, Solna, Sweden.
  • Groenheit R; Public Health Agency of Swedengrid.419734.c, Solna, Sweden.
  • Werngren J; Public Health Agency of Swedengrid.419734.c, Solna, Sweden.
Antimicrob Agents Chemother ; 66(12): e0102622, 2022 12 20.
Article en En | MEDLINE | ID: mdl-36409105
ABSTRACT
High-confidence resistance mutations for new and repurposed anti-TB drugs, such as delamanid (DLM) and pretomanid (Pa), are rare and more data are needed in order to correctly interpret the results generated by genotypic drug susceptibility testing. In this study performed on clinical Mycobacterium tuberculosis complex isolates, we report that in the Swedish strain collection the ddn mutation Trp20Stop is found exclusively among DLM and Pa resistant (Pa MIC >16 mg/L) isolates assigned to lineage 4.5.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis / Nitroimidazoles Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis / Nitroimidazoles Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Suecia